The Substance Abuse and Mental Health Services Administration yesterday issued guidance for health care and addiction professionals using methadone, naltrexone or buprenorphine to treat patients with opioid use disorder. Mandated by the Comprehensive Addiction and Recovery Act, the guidance offers appropriate prescribing practices and strategies for supporting patients. It also educates patients, families and the general public about the medications. “We know that people can and do recover from opioid use disorders when they receive appropriate treatment, and medication-assisted treatment’s success in treating opioid use disorders is well documented,” said Elinore McCance-Katz, M.D., assistant secretary for mental health and substance use at the Department of Health and Human Services. For an AHA toolkit and other resources to help hospitals and health systems tackle the opioid crisis, visit www.aha.org/opioidtoolkit.

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 80 rural consortia $1 million each to help prevent, treat and support recovery for patients…
Headline
The National Association of Attorneys General yesterday urged congressional leaders to remove federal barriers to opioid use disorder treatment.
Headline
The number of naloxone prescriptions dispensed from retail pharmacies doubled in 2018, but access to the emergency opioid overdose treatment still varies…
Headline
The Department of Health and Human Services seeks input from health care providers and other stakeholders for a report to Congress on ensuring legitimate…
Headline
The Department of Health and Human Services yesterday sent Congress its plan to help states develop and expand innovative strategies to provide housing-related…
Headline
Qualified nonprofits and government agencies may submit through Aug. 25 letters of intent to apply for funding from the Foundation for Opioid Response Efforts…